S. Muoio & Co’s Aimmune Therapeutics AIMT Stock Holding History

S. Muoio & Co’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-90,000	Closed	-$3.1M	–	93
2020 Q3	$3.1M	Buy	+90,000	New	+$1.92M	3.52%	5

S. Muoio & Co's AIMT Position: Q4 2020 in Review

S. Muoio & Co sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 90,000 shares — an estimated $3.1M sold.

S. Muoio & Co first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $3.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

S. Muoio & Co reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
S. Muoio & Co sold 90,000 Aimmune Therapeutics shares in Q4 2020, an estimated $3.1M.
S. Muoio & Co first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
S. Muoio & Co's Aimmune Therapeutics position peaked at $3.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on S. Muoio & Co's 13F filing for Q4 2020, filed 16 Feb 2021.